Normocalcemic primary hyperparathyroidism
- PMID: 20485897
- PMCID: PMC3127400
- DOI: 10.1590/s0004-27302010000200004
Normocalcemic primary hyperparathyroidism
Abstract
Primary hyperparathyroidism is a common disorder of mineral metabolism characterized by incompletely regulated, excessive secretion of parathyroid hormone from one or more of the parathyroid glands. The historical view of this disease describes two distinct entities marked by two eras. When primary hyperparathyroidism was first discovered about 80 years ago, it was always symptomatic with kidney stones, bone disease and marked hypercalcemia. With the advent of the multichannel autoanalyzer about 40 years ago, the clinical phenotype changed to a disorder characterized by mild hypercalcemia and the absence of classical other features of the disease. We may now be entering a 3rd era in the history of this disease in which patients are being discovered with normal total and ionized serum calcium concentrations but with parathyroid hormone levels that are consistently elevated. In this article, we describe this new entity, normocalcemic primary hyperparathyroidism, a forme fruste of the disease.
References
-
- Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, et al. A non (1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem. 44:805–9. - PubMed
-
- D'Amour P, Brossard J-H, Rousseau L, et al. Structure of non-(1–84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int. 2005;68:998–1007. - PubMed
-
- Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1–84. Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res. 2001;16:605–14. - PubMed
-
- Silverberg SJ, Brown I, LoGerfo P, Gao P, Cantor T, Bilezikian JP. Clinical utility of an immunoradiometric assay for whole PTH (1–84) in primary hyperparathyroidism. J Clin Endocrinol Metab. 2003;88:4725–30. - PubMed
-
- Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003;88:4641–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources